CD109 Antibody / CD109 antigen

The CD109 antibody is a useful tool for studing and characterizing the CD109 protein. Also known as the glycosylphosphatidylinositol-anchored glycoprotein, CD109 is a cell surface protein that has been linked to a variety of cellular processes, including cell proliferation, migration, and survival. Research has shown that CD109 is often overexpressed in various types of cancer, including lung, breast, and skin cancer, making it a potential target for therapeutic development. One of the most intriguing aspects of CD109 protein is its role in regulating the immune response. Studies have shown that CD109 can modulate the activity of T cells, a crucial component of the immune system that plays a key role in fighting off cancer cells. By targeting CD109, researchers hope to manipulate the immune response in such a way that cancer cells are more effectively targeted and destroyed. In addition to its role in cancer, CD109 protein has also been implicated in other diseases, such as fibrosis and inflammation. Understanding the various functions of CD109 can provide valuable insights into the underlying mechanisms of these diseases, potentially leading to new treatment options for patients.

 

Various techniques use CD109 antibody for detecting CD109 expression, including flow cytometry, western blot, immunohistochemistry, immunocytochemistry, immunofluorescence, and ELISA.

Flow cytometry is a powerful tool for analyzing single cells in suspension, making it an ideal method for studying CD109 expression on the cell surface. Using a specific CD109 antibody in a flow cytometry assay, researchers can quantitatively measure the levels of CD109 on various cell types.

Western blotting is another common technique used to detect and quantify protein levels in cell lysates. By using a CD109 antibody in a western blot assay, researchers can determine the molecular weight and expression levels of CD109 in different cell or tissue samples.

Immunohistochemistry is a valuable technique for visualizing protein expression in tissue sections. Using CD109 antibody in an immunohistochemistry assay, researchers can localize where CD109 is expressed within tissues, allowing for insights into its function and distribution.

Immunocytochemistry is a technique used to visualize protein expression in fixed cells. With a CD109 antibody in an immunocytochemistry assay, researchers can study the subcellular localization of CD109 within cells, providing further insight into its role in cellular processes.

Immunofluorescence is a powerful imaging technique that uses fluorescently labeled antibodies to detect specific proteins within cells or tissues. By using a CD109 antibody in an immunofluorescence assay, researchers can visualize the distribution of CD109 in cells or tissues with high resolution.

ELISA (enzyme-linked immunosorbent assay) is a sensitive technique used to quantify protein levels in biological samples. A CD109 antibody can be used to measure the concentration of CD109 in serum, plasma, or cell lysates, providing valuable information on its expression levels in different biological contexts.

Choosing the right CD109 antibody and assay for your research is crucial for accurate and reliable results. By utilizing a combination of techniques such as flow cytometry, western blot, immunohistochemistry, immunocytochemistry, immunofluorescence, and ELISA, researchers can gain a comprehensive understanding of CD109 expression and function in various biological systems.